Patient presents with clinical manifestations consistent with skin candidiasis (cutaneous candidiasis, yeast infection skin, moniliasis).  The affected area, located [specify location: e.g., intertriginous area of the groin, axillae, inframammary folds, perianal region], exhibits [describe lesion morphology: e.g., erythematous plaques with satellite lesions, pustules, scaling, maceration].  Patient reports [describe symptoms: e.g., pruritus, burning sensation, pain].  Differential diagnoses considered include intertrigo, psoriasis, contact dermatitis, and seborrheic dermatitis.  Diagnosis of skin candidiasis is based on clinical presentation and may be confirmed with potassium hydroxide (KOH) preparation demonstrating pseudohyphae and budding yeast.  Risk factors for cutaneous candidiasis identified include [list applicable factors: e.g., obesity, diabetes mellitus, antibiotic use, immunosuppression, warm and humid environment, occlusive clothing].  Treatment plan includes topical antifungal therapy with [specify medication: e.g., clotrimazole, miconazole, nystatin] applied to the affected area [specify frequency: e.g., twice daily] for [specify duration: e.g., two weeks].  Patient education provided regarding proper hygiene, keeping the area dry, and avoiding tight-fitting clothing.  Follow-up appointment scheduled in [specify timeframe: e.g., two weeks] to assess treatment response.  ICD-10 code B37.9 Candidiasis, unspecified is documented for billing purposes.